Clinical trial
RSV Challenge in Healthy Adults
NCT00100373 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00100373 |
|---|---|
| Title | RSV Challenge in Healthy Adults |
| Official title | Characterization of the Immune Response and Viral Shedding to Experimental Infection With Respiratory Syncytial Virus, Strain A-2, in Healthy Adults Ages 21 to 40 Years Old |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Respiratory Infections, Acute, Respiratory Syncytial Virus |
| Intervention type | Drug |
| Interventions | RSV challenge material |
| Enrollment | 13 |
| Start date | Sep 1, 2004 |
| Completion | May 1, 2005 |
| First posted | Dec 31, 2004 |
| Last update posted | Aug 27, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: